Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

Abstract Background Hematopoietic stem cell transplantation (HSCT) is a standard therapy strategy for most malignant disorders in children. However, transplant-related pneumonia remains a major therapy challenge and mesenchymal stromal cells (MSCs) are rarely reported in HSCT-related pneumonia. The...

Full description

Bibliographic Details
Main Authors: Yuhua Qu, Xu Yang, Xiaohong Zhang, Shanshan Liu, Xiaoping Liu, Xiaodan Liu, Ailing Luo, Mansi Cai, Yaping Yan, Ling Xu, Hua Jiang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stromal cell (MSC)
Hematopoietic stem cell transplantation (HSCT)
Pneumonia
Severe pneumonia
Online Access:https://doi.org/10.1186/s13287-022-02960-7

Internet

https://doi.org/10.1186/s13287-022-02960-7

Similar Items